Board of Directors
Targeting, Attacking, and Eradicating Cancers®
Chief Executive Officer
Dr. Moon has served as Chief Executive Officer since February 2014. Dr. Moon graduated with honors from the School of Dentistry of Seoul National University in Korea and from Moscow Medical School in Russia where he concentrated in Head and Neck Surgery. He was appointed as a member of the Korea-Russia Association and also works as a consultant of the Academy of Foreign Affairs and National Security.
Chief Operating Officer
Mr. Chi has been with SillaJen as Executive Vice President and Chief Operating Officer since July 2015, and formerly, he was the Chief Business Officer at SillaJen Biotherapeutics, Inc. from 2014-2015, where he was highly responsible for technology management and internal control. Prior his position at SillaJen Biotherapeutics, he served as an external director of SillaJen, responsible for planning business strategy for three years. Mr. Chi also served as professor and director at Pusan National University since 1991, where he conducted research in the field of Agency Theory and Technology Management, as well as MBA programs for Samsung. He holds an MBA degree from California State University, Los Angeles, and holds a Master of Professional Accounting degree and a Ph.D. in Business Administration from the University of Washington.
Chief Financial Officer
Mr. Song has served as the Executive Director and the Head of Management Planning and Management Support since January 2017, where he oversees general corporate management and planning. Prior to joining SillaJen, Mr. Song served as a director at KEB Hana Bank, managing corporate banking for over 20 years. Mr. Song graduated from Yonsei University with a degree in political science & international relations, and received his masters in public administration from Yonsei University graduate school.
Prof. Kook was appointed as an external director September 2016, where he is responsible for providing objective assessment and an independent advice. Presently, he is professor of Dept. of Microbiology, Seoul National University College of Medicine in Korea and has held that position since September 2000.Prof. Kook also held research position at Mount Sinai Hospital Division of Medical Oncology in New York, USA. He graduated from the School of Medicine of Seoul National University with B.A. degree and received his M.D. of Medical Microbiology from Seoul National University.
Dr. Kim was appointed as an external director September 2016, where he is responsible for providing an independent review of the company. He had served as the President of Korea University Medical Center Anam Hospital and on the jury of Health Insurance Review & Assessment Service. Dr. Kim has currently served as the chairman of the Committee of Health of the Korean Medical Association. He graduated from Korea University and received his M.D. of College of Medicine from Korea University.
Mr. Park was appointed as an external director March 2015, where he is responsible for providing objective assessment and independent review. He has managed several investment companies as a CEO for over 10 years. Mr. Park graduated from Seoul National University and received Master’s degree in IB Finance from the George Washington University in USA.
Mr. Noh was appointed as an auditor March 2016, where he is responsible for monitoring regularly and rigorously financial performance and internal control systems of the company by using his deep expertise from long and broader range of experiences in the finance and accounting. He served as a CEO of Hyundai Merchant Marine Co., Executive Vice President of Hyundai Capital and external director at Hyundai Securities for over 7 years. Mr. Noh also served as CEO of Seoul National University Techno Holdings. He graduated from dept. of Business Administration of Seoul National University and received a Master’s degree of Industrial Engineering from KAIST. Also, He achieved Master of Accountancy from George Washington Univ. School of Business in USA. He is also a registered CPA in Korea and USA.